INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio Update as at 31 July 2013
Total net assets |
£176.3m |
NAV per share |
319.6p |
Share price |
268.8p |
Total value of unquoted investments |
£26.0m |
Total number of portfolio companies |
71 |
Cash |
2% NAV |
Cash committed and reserved to unquoted investments |
(4.1%) NAV |
Top Ten Holdings
Company Name |
% NAV |
Celgene |
7.6 |
Biogen |
7.4 |
Amgen |
7.3 |
Gilead |
7.3 |
Regeneron |
6.7 |
Alexion |
4.5 |
Aptiv |
3.4 |
Vertex |
3.1 |
Onyx |
2.9 |
Incyte |
2.6 |
|
----------- |
Total |
52.8 |
Geographical Allocation |
% |
United States & Canada |
92 |
Europe |
6 |
Cash |
2 |
|
----------- |
Total |
100 |
Quoted/Unquoted allocation |
% |
Quoted |
83 |
Unquoted |
15 |
Cash |
2 |
|
----------- |
Total |
100 |
BNP Paribas Secretarial Services Limited
Company Secretary
27 AUGUST 2013